Comments: NY A02904 | 2019-2020 | General Assembly

Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.

Spectrum: Moderate Partisan Bill (Democrat 4-1)

Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2019 New York A02904 at this time.

Social Comments on NY A02904

feedback